Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas T MacDonald

Showing results (71-80 of 148) with videos related to

Pageof 15
Sort By:
Gastroenterology|June 10, 2009
Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gutRoberta Caruso, Massimiliano Sarra, Carmine Stolfi, et al.
Gastroenterology|April 8, 2014
A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel diseaseAnna Vossenkämper, Christian Hundsrucker, Kevin Page, et al.
European Journal of Immunology|October 6, 2007
IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cellsMassimo C Fantini, Agelamaria Rizzo, Daniele Fina, et al.
The American Journal of Gastroenterology|December 9, 2010
Involvement of CD40-CD40 ligand in uncomplicated and refractory celiac diseaseAntonio Di Sabatino, Laura Rovedatti, Stefania Vetrano, et al.
Gastroenterology|September 10, 2009
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamineCarmine Stolfi, Massimiliano Sarra, Roberta Caruso, et al.
Inflammatory Bowel Diseases|February 27, 2010
Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseasesMassimiliano Sarra, Ivan Monteleone, Carmine Stolfi, et al.
Inflammatory Bowel Diseases|November 21, 2007
Matrix metalloproteinase-3 production by gut IgG plasma cells in chronic inflammatory bowel diseaseJohn N Gordon, Karen M Pickard, Antonio Di Sabatino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gammaCameron P Simmons, Nathalie S Goncalves, Marjan Ghaem-Maghami, et al.
The British Journal of Nutrition|January 20, 2017
Can probiotics modulate human disease by impacting intestinal barrier function?Peter A Bron, Michiel Kleerebezem, Robert-Jan Brummer, et al.
Internal and Emergency Medicine|May 10, 2011
Mucosal changes induced by ischemia-reperfusion injury in a jejunal loop transplanted in oropharynxAntonio Di Sabatino, Laura Brunetti, Paolo Biancheri, et al.
Pageof 15

Showing results (71-80 of 148) with videos related to

Sort By:
Pageof 15
Gastroenterology|June 10, 2009
Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gutRoberta Caruso, Massimiliano Sarra, Carmine Stolfi, et al.
Gastroenterology|April 8, 2014
A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel diseaseAnna Vossenkämper, Christian Hundsrucker, Kevin Page, et al.
European Journal of Immunology|October 6, 2007
IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cellsMassimo C Fantini, Agelamaria Rizzo, Daniele Fina, et al.
The American Journal of Gastroenterology|December 9, 2010
Involvement of CD40-CD40 ligand in uncomplicated and refractory celiac diseaseAntonio Di Sabatino, Laura Rovedatti, Stefania Vetrano, et al.
Gastroenterology|September 10, 2009
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamineCarmine Stolfi, Massimiliano Sarra, Roberta Caruso, et al.
Inflammatory Bowel Diseases|February 27, 2010
Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseasesMassimiliano Sarra, Ivan Monteleone, Carmine Stolfi, et al.
Inflammatory Bowel Diseases|November 21, 2007
Matrix metalloproteinase-3 production by gut IgG plasma cells in chronic inflammatory bowel diseaseJohn N Gordon, Karen M Pickard, Antonio Di Sabatino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gammaCameron P Simmons, Nathalie S Goncalves, Marjan Ghaem-Maghami, et al.
The British Journal of Nutrition|January 20, 2017
Can probiotics modulate human disease by impacting intestinal barrier function?Peter A Bron, Michiel Kleerebezem, Robert-Jan Brummer, et al.
Internal and Emergency Medicine|May 10, 2011
Mucosal changes induced by ischemia-reperfusion injury in a jejunal loop transplanted in oropharynxAntonio Di Sabatino, Laura Brunetti, Paolo Biancheri, et al.
Pageof 15